Tokyo startup confirms efficacy of iPS cell-derived heart muscle transplants

by | Dec 13, 2025 | Asia

Spread the love
According to Friday’s announcement, the transplant was performed on 10 patients, and no major safety issues were confirmed.

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments